China Feihe Ltd stock (KYG2108Y1052): Stable Hong Kong trading after latest annual results

China Feihe Ltd shares on the Hong Kong Stock Exchange continue to trade steadily following the company’s FY 2024 results, with investors in Hong Kong and abroad watching how the infant formula producer navigates China’s evolving dairy market.

China Feihe Ltd shares on the Hong Kong Stock Exchange continued to trade in relatively calm fashion in recent sessions, as investors digested the company’s most recently published annual figures and assessed demand trends in China’s infant milk formula market, according to coverage of the Hong Kong-listed stock as of 05/2025 by local financial media. The stock, which trades under stock code 6186 on HKEX in Hong Kong dollars, remains actively traded even though price moves have been modest in late May 2026, reflecting a wait-and-see stance among market participants in the company’s home market of China and the broader Hong Kong market.

China Feihe, headquartered in Beijing and listed primarily in Hong Kong, reported its latest full-year financial results for FY 2024 on 03/28/2025, providing investors with updated visibility on revenue, profit margins, and dividend payments from its core infant milk formula and dairy businesses, based on the company’s results announcement published on its investor relations website on that date. According to that FY 2024 results release, management outlined how sales performance in domestic China, product mix changes across premium and mass-market infant formula, and marketing investments influenced the company’s profitability and cash generation for the year ended 12/31/2024, giving Hong Kong and international shareholders a detailed snapshot of operations in the Chinese dairy sector at that point in time.

The stock traded around its recent Hong Kong dollar range on the Hong Kong Stock Exchange in the final week of May 2026, with volumes remaining consistent with levels seen earlier in the year, according to exchange data summarized by regional market news services as of 05/31/2026. For investors in the home market, the focus is on how China Feihe can sustain earnings in the face of demographic headwinds in mainland China and increased competition from both domestic and international infant formula brands, developments that were discussed in conjunction with the FY 2024 numbers released at the end of March 2025.

As of: 06/01/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: China Feihe
• Sector/industry: Dairy products and infant milk formula
• Headquarters/country: Beijing, China
• Core markets: Mainland China, selected export markets
• Key revenue drivers: Branded infant milk formula products, adult milk powder and other dairy-based nutrition products
• Home exchange/listing venue: Hong Kong Stock Exchange (6186)
• Trading currency: HKD

China Feihe Ltd: core business model

China Feihe Ltd focuses on producing and marketing branded infant milk formula and other dairy-based nutrition products primarily for Chinese consumers, with revenue closely tied to brand strength, distribution reach, and shifting birth and consumption patterns in mainland China.

What banks and research houses say about China Feihe Ltd

No verified analyst coverage was identified at the time of publication.

Conclusion

China Feihe Ltd’s Hong Kong-listed shares are trading steadily as of late May 2026, with investors weighing the implications of the company’s FY 2024 results released on 03/28/2025 against ongoing demographic and competitive pressures in China’s infant formula market. The absence of clearly documented, up-to-date analyst ratings from major banks leaves the market to rely more heavily on company disclosures, sector trends, and trading activity on the Hong Kong Stock Exchange when forming expectations for the stock’s medium-term development.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.